Kageyama Y - Search Results

1

Photodynamic therapy using talaporfin sodium for synovial membrane from rheumatoid arthritis patients and collagen-induced arthritis rats.

Torikai E, Kageyama Y, Kohno E, Hirano T, Koide Y, Terakawa S, Nagano A. Torikai E, et al. Among authors: kageyama y. Clin Rheumatol. 2008 Jun;27(6):751-61. doi: 10.1007/s10067-007-0794-8. Epub 2007 Dec 8. Clin Rheumatol. 2008. PMID: 18066613

2

Treatment with anti-TNF-alpha antibody infliximab reduces serum IL-15 levels in patients with rheumatoid arthritis.

Kageyama Y, Takahashi M, Torikai E, Suzuki M, Ichikawa T, Nagafusa T, Koide Y, Nagano A. Kageyama Y, et al. Clin Rheumatol. 2007 Apr;26(4):505-9. doi: 10.1007/s10067-006-0312-4. Epub 2006 May 6. Clin Rheumatol. 2007. PMID: 16680388 Clinical Trial.

3

Anti-tumor necrosis factor-alpha antibody treatment reduces serum CXCL16 levels in patients with rheumatoid arthritis.

Kageyama Y, Torikai E, Nagano A. Kageyama Y, et al. Rheumatol Int. 2007 Mar;27(5):467-72. doi: 10.1007/s00296-006-0241-1. Rheumatol Int. 2007. PMID: 17051360 Clinical Trial.

4

The effect of infliximab on chemokines in patients with rheumatoid arthritis.

Torikai E, Kageyama Y, Suzuki M, Ichikawa T, Nagano A. Torikai E, et al. Among authors: kageyama y. Clin Rheumatol. 2007 Jul;26(7):1088-93. doi: 10.1007/s10067-006-0453-5. Epub 2006 Nov 17. Clin Rheumatol. 2007. PMID: 17111092

5

The effect of methotrexate on bone metabolism markers in patients with rheumatoid arthritis.

Torikai E, Kageyama Y, Takahashi M, Nagano A. Torikai E, et al. Among authors: kageyama y. Mod Rheumatol. 2006;16(6):350-4. doi: 10.1007/s10165-006-0517-z. Epub 2006 Dec 20. Mod Rheumatol. 2006. PMID: 17164995

6

Etanercept reduces the serum levels of interleukin-23 and macrophage inflammatory protein-3 alpha in patients with rheumatoid arthritis.

Kageyama Y, Ichikawa T, Nagafusa T, Torikai E, Shimazu M, Nagano A. Kageyama Y, et al. Rheumatol Int. 2007 Dec;28(2):137-43. doi: 10.1007/s00296-007-0388-4. Epub 2007 Jul 10. Rheumatol Int. 2007. PMID: 17619881

7

Etanercept reduces the oxidative stress marker levels in patients with rheumatoid arthritis.

Kageyama Y, Takahashi M, Nagafusa T, Torikai E, Nagano A. Kageyama Y, et al. Rheumatol Int. 2008 Jan;28(3):245-51. doi: 10.1007/s00296-007-0419-1. Epub 2007 Jul 28. Rheumatol Int. 2008. PMID: 17661050

8

Methotrexate reduces the levels of pentosidine and 8-hydroxy-deoxy guanosine in patients with rheumatoid arthritis.

Kageyama Y, Takahashi M, Nagafusa T, Torikai E, Nagano A. Kageyama Y, et al. Mod Rheumatol. 2007;17(5):398-402. doi: 10.1007/s10165-007-0607-6. Epub 2007 Oct 19. Mod Rheumatol. 2007. PMID: 17929132

9

Comparison between resection arthroplasty alone and resection arthroplasty with arthrodesis of the first MTP joint for rheumatoid forefoot deformities.

Torikai E, Kageyama Y, Suzuki M, Ichikawa T, Nagano A. Torikai E, et al. Among authors: kageyama y. Mod Rheumatol. 2008;18(5):486-91. doi: 10.1007/s10165-008-0086-4. Epub 2008 Jun 24. Mod Rheumatol. 2008. PMID: 18568452

10

Leukotrien B4-induced interleukin-1 beta in synovial cells from patients with rheumatoid arthritis.

Kageyama Y, Koide Y, Miyamoto S, Yoshida TO, Inoue T. Kageyama Y, et al. Scand J Rheumatol. 1994;23(3):148-50. doi: 10.3109/03009749409103049. Scand J Rheumatol. 1994. PMID: 8016588

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

531 results

Search Page

Filters